Results of a phase III trial of erlotinib combined with cisplatin and gemcitabine in advanced non-small cell lung cancer [abstract 7010]. 2004 Annual Meeting Proceedings - Gatzmeier,U.; Pluzanska,A.; Szczesna,A. (J Clin Oncol, 2004)